Table 1.
Patients characteristics for ten monitored SCLC patients with confirmed SIADH
| Case | Gender | Age at diagnosis (years) | Sodium level at therapy start (mmol/l) | TNM | Overall survival (months) |
|---|---|---|---|---|---|
| 1 |
m |
52 |
121 |
T4 N1 M1b (brain) |
19 |
| 2 |
m |
70 |
121 |
T4 N3 M1b (hepatic, osseous, pleura) |
8 |
| 3 |
m |
66 |
118 |
T4 N3 M1b (cervical, pulmonal, osseous) |
8 |
| 4 |
f |
62 |
115 |
T4 N2 M0 |
20, lives |
| 5 |
f |
62 |
118 |
T4 N3 M1b (hepatic) |
11 |
| 6 |
m |
66 |
120 |
T3 N2 M0 |
11 |
| 7 |
m |
50 |
116 |
T2a N1 M0 |
2 |
| 8 |
f |
63 |
117 |
T4 N3 M0 |
11, lives |
| 9 |
m |
71 |
122 |
T4 N3 M1a |
5 |
| 10 | m | 65 | 117 | T4 N3 M1b (hepatic, osseous) | 10 |
(Localisation of the metastases indicated in parentheses).